Copyright
©The Author(s) 2015.
World J Transl Med. Dec 12, 2015; 4(3): 113-122
Published online Dec 12, 2015. doi: 10.5528/wjtm.v4.i3.113
Published online Dec 12, 2015. doi: 10.5528/wjtm.v4.i3.113
Figure 1 The procedure of pervasa vasorum transplantation.
Human iPSCdECs were mixed with Matrigel® Matrix and the mixtures were put into the subcutaneous regions around the WI-injured femoral arteries. WI: Wire injury; iPSC: Induced pluripotent stem cell; VEC: Vascular endothelial cell; iPSdECs: iPSC-derived VECs; αAGM1: Anti-asialo GM1 monoclonal antibody.
- Citation: Nishio M, Nakahara M, Saeki K, Fujiu K, Iwata H, Manabe I, Yuo A, Saeki K. Pro- vs anti-stenotic capacities of type-I vs type-II human induced pluripotent-derived endothelial cells. World J Transl Med 2015; 4(3): 113-122
- URL: https://www.wjgnet.com/2220-6132/full/v4/i3/113.htm
- DOI: https://dx.doi.org/10.5528/wjtm.v4.i3.113